**Question:** All of the following are true about Metoclopramide except

A. Metoclopramide is a dopamine antagonist.
B. Metoclopramide has a direct effect on the gastrointestinal tract.
C. Metoclopramide is a beta-blocker.
D. Metoclopramide is a calcium channel blocker.

**Correct Answer:** C. Metoclopramide is a beta-blocker.

**Core Concept:** Metoclopramide is a medication primarily used for its gastrointestinal (GI) motility-enhancing properties. It belongs to a class of drugs called dopamine antagonists, which primarily act on the dopamine receptors in the brain and GI tract.

**Why the Correct Answer is Right:** Metoclopramide is a selective antagonist of dopamine D2 receptors, which are mainly responsible for suppressing the movement of the gastrointestinal tract. This helps in improving symptoms like nausea, vomiting, and gastroparesis. It does not have a direct effect on the gastrointestinal tract as stated in option B.

**Why Each Wrong Option is Incorrect:**

A. Metoclopramide is a dopamine antagonist, not a beta-blocker like option C. Dopamine antagonists block dopamine receptors, while beta-blockers work by blocking beta-adrenergic receptors.

B. Although Metoclopramide does have GI motility-enhancing effects, it is primarily acting through dopamine antagonism, not by having a direct effect on the GI tract like option B states.

D. Metoclopramide is a dopamine antagonist, not a calcium channel blocker (CCB). Calcium channel blockers reduce calcium influx into cells, affecting cardiac and smooth muscle function, while Metoclopramide's action is on dopamine receptors.

**Clinical Pearl:** Understanding the pharmacodynamics of Metoclopramide helps in appreciating its mechanism of action and therapeutic uses in gastrointestinal disorders. Dopamine antagonism is essential for its therapeutic effects, and it does not work through calcium channel blockage or direct GI tract effects.